Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05834400 · ClinicalTrials.gov registry record · NA

Lymphatic System Stimulation in Heart Failure

A NA study of Heart Failure, sponsored by Rutgers, The State University of New Jersey.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT05834400: Recruiting NA study of Heart Failure, sponsored by Rutgers, The State University of New Jersey.

NCT05834400 is a NA study of Heart Failure that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 80 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05834400, a NA study of Heart Failure, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The goal of this pilot clinical trial is to obtain preliminary data on the effects of lymphatic exercise training in patients with heart failure. The main question\[s\] it aims to answer are: 1. Does performing lymphatic exercise decrease fluid overload symptoms (shortness of breath, lower legs swelling, fatigue), thoracic fluid content, and body fluid level? 2. Does performing lymphatic exercise improve sleep and quality of life (QOL)? Participants with heart failure will be randomly assigned into two groups: Group 1 will receive training on lymphatic exercises, and will perform these training for 4 weeks. This group will also be trained to monitor daily their weight, heart rate and blood pressure, and fluid overload symptoms. Group 2 will be trained to daily monitor their weight, heart rate and blood pressure, and fluid overload symptoms. This group will not perform the lymphatic exercises. Researchers will compare the two groups at the baseline and after delivering the 4 week-interventions to see 1. if lymphatic exercise helped decrease symptoms associated with fluid overload like shortness of breath, lower leg swelling, and fatigue. 2. if lymphatic exercises decreased thoracic fluid content and total body fluid level . 3. if the lymphatic exercise helped improve sleep and quality of life (QOL).

Primary Outcome

Fluid overload symptoms include shortness of breath, difficulty breathing when lying flat, cough, lack of energy, swelling of legs or ankles, and waking up breathless at nigh swelling of the lower extremities. These symptoms are measured by The Memorial Symptom Assessment Scale - Heart Failure (MSAS-HF). Individual scores are summed for each symptom present, rating frequency, severity, and distress to obtain a total symptom score for each symptom with a possible range of 0-13. Higher scores indi

Conditions Studied

Interventions

  • BEHAVIORAL The Optimal Lymph FLow (TOLF)
  • BEHAVIORAL Daily Monitoring

Study Locations (1)

New Jersey

  • Cooper University Health Care (Cooper) - Camden

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2023-06-15
Est. Completion 2025-10
Phase NA

What NCT05834400 shows while recruiting

NCT05834400 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which The Optimal Lymph FLow (TOLF) is the first listed.

NCT05834400 reports a single indexed study location in New Jersey.

Frequently Asked Questions

What is clinical trial NCT05834400 about?

NCT05834400 is a clinical study titled "Lymphatic System Stimulation in Heart Failure". The goal of this pilot clinical trial is to obtain preliminary data on the effects of lymphatic exercise training in patients with heart failure. The main question\[s\] it aims to answer are: 1. Does performing lymphatic exercise decrease fluid overload symptoms (shortness of breath, lower legs swe...

What is the current status of trial NCT05834400?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2023-06-15. Estimated completion is 2025-10.

What conditions does trial NCT05834400 study?

This clinical trial studies the following conditions: Heart Failure.

What interventions are being tested in trial NCT05834400?

The interventions under investigation include: The Optimal Lymph FLow (TOLF) (BEHAVIORAL), Daily Monitoring (BEHAVIORAL).

Who is sponsoring clinical trial NCT05834400?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05834400 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05834400's enrollment target sits among peer trials

80 229th of 397 higher than 167 of 397 other Heart Failure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05834400, the US trial registry maintained by the National Library of Medicine. NCT05834400 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.